Joslin announces first international affiliate ...( [Boston December 11 2003] -- Joslin D...),Health

[Boston, December 11, 2003] -- Joslin Diabetes Center and the Gulf Diabetes Specialists Center in Bahrain have signed a five-year agreement to establish a state-of-the-art treatment center to provide specialty care for people with diabetes. Located in Manama next to the Salmaniya Medical Complex and Arabian Gulf University, the Joslin Diabetes Center Affiliate Bahrain is the region's first medical center devoted entirely to the treatment of diabetes and related complications. The new center is in the final stages of construction, and is expected to officially open early in 2004.

According to the World Health Organization (WHO), diabetes currently affects more than 25.5 percent of the Bahraini population while 40 percent of the population is at risk of developing the disease. This is one of the highest population percentages with diabetes in the world. (See sidebar: separate document for additional background on diabetes in Bahrain.)

"The Middle East is facing a health crisis as a substantial percentage of its population either has diabetes or is at risk of developing diabetes," said C. Ronald Kahn, M.D., President and Director, Joslin Diabetes Center, and the Mary K. Iacocca Professor of Medicine at Harvard Medical School. "This Affiliate relationship allows the expertise of Joslin to be transmitted to an outstanding team of Bahraini medical professionals and enables Joslin's proven approach to diabetes treatment to be brought to bear on this epidemic."

The agreement brings to Bahrain Joslin Diabetes Center's respected disease management programs designed to help prevent complications. The Joslin Diabetes Center Affiliate Bahrain will leverage telemedicine technology that enables Joslin specialists in Boston to assess images of the retina using the Joslin Vision Network, a digital retinal evaluation tool that enables the early diagnosis and treatment of diabetic retinopathy.

In addition, the Bahrain center will have access
'"/>

Contact: Marge Dwyer
marjorie.dwyer@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
11-Dec-2003

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Immune cells may play important role in progression of type 1 diabetes, Joslin researchers find
2. Its never too late to start exercising and losing weight , Joslin study shows
3. Study shows Joslins Care Ambassador program helps kids with diabetes better manage the disease
4. Joslin and Beth Israel Deaconess Medical Center sign new joint venture clinical agreement
5. The Gerontological Society of America announces Hartford Fellowship recipients
6. TB Alliance announces new drug discovery program with GlaxoSmithKline
7. ASGE announces grant recipients in annual research awards program
8. Novartis announces collaboration with Bayer for EMSELEX
9. American College of Chest Physicians announces new Critical Care Institute
10. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
11. Department of Energy announces new agreement with USC, national labs and private company